Référentiel des médicaments
Luspatercept
Luspatercept is a medicine in the class miscellaneous. It is used for anemia.
- Classe médicamenteuse: Miscellaneous
- Indications: anemia
Dernière mise à jour Sources: US FDA label
Réservé aux professionnels de santé — à titre de référence uniquement. Cette page est un bref résumé, pas un avis médical, et ne remplace ni la notice officielle ni le jugement clinique. Vérifiez toujours avant de prescrire ou de délivrer.
Le contenu clinique de cette page n'est disponible qu'en anglais.
L'essentiel
- Classe médicamenteuse
- Miscellaneous
- Code ATC
- B03XA06
- Formes courantes
- injection
- Dosages courants
- 25 mg
- Noms commerciaux
- 3
- Pays et marchés
- 3
Indications
Mécanisme d'action
Recombinant fusion protein that binds several endogenous TGF-β superfamily ligands, diminishing Smad2/3 signaling and promoting erythroid maturation, thereby increasing erythropoiesis.
Posologie adulte habituelle (résumé de la notice)
Beta thalassemia anemia requiring regular RBC transfusions: start 1 mg/kg subcutaneously once every 3 weeks; increase to 1.25 mg/kg if no reduction in RBC transfusion burden; maximum 1.25 mg/kg
Grossesse et allaitement
- Grossesse
- Unsafe May cause fetal harm: in rats and rabbits it caused fetal death, poor growth and malformations. No human data. Do not use in pregnancy; women who could become pregnant need a pregnancy test before starting and effective contraception during treatment and for 3 months after.
- Allaitement
- Unknown No human milk data; it passes into rat milk. LactMed: as a large protein, milk levels are likely very low and poorly absorbed, but no data yet. US label: breastfeeding not recommended during treatment and for 3 months after the last dose.
Effets indésirables signalés
- Fatigue
- Headache
- Musculoskeletal pain
- Arthralgia
- Dizziness/vertigo
- Nausea
Précautions particulières
- Thromboembolic events reported in beta thalassemia; consider thromboprophylaxis in at-risk patients and monitor.
- Hypertension: monitor blood pressure before each administration and treat with antihypertensives.
- Extramedullary hematopoietic masses in beta thalassemia; monitor and discontinue for serious complications.
Informez votre pharmacien ou votre médecin en cas de grossesse ou d'allaitement, de maladie rénale ou hépatique, d'allergies, ainsi que de tout autre médicament ou complément que vous prenez.
Réservé aux membres Pro+
Débloquer la page complète
Créez un compte et lancez un essai Pro+ pour ouvrir la monographie complète de Luspatercept : posologie, grossesse et allaitement, effets indésirables, mises en garde et toutes les interactions.
- Dosing by age, kidney and liver function, and further dose lines
- Renal and hepatic dose adjustments
- Dosing in older adults
- How to give it
- Pharmacokinetics
- Patient counselling points
- IV preparation and dilution
Essayez Pro+ gratuitement pendant 7 jours sur le web. Sans carte.
Autres médicaments de cette classe
Questions fréquentes
What is Luspatercept used for?
Luspatercept is a medicine in the class miscellaneous. It is used for Anemia, Myelodysplastic syndromes, Thalassemia.
What side effects have been reported with Luspatercept?
Fatigue, Headache, Musculoskeletal pain, Arthralgia, Dizziness/vertigo, Nausea.
Can Luspatercept be taken in pregnancy or while breastfeeding?
Pregnancy: Unsafe. May cause fetal harm: in rats and rabbits it caused fetal death, poor growth and malformations. No human data. Do not use in pregnancy; women who could become pregnant need a pregnancy test before starting and effective contraception during treatment and for 3 months after. Breastfeeding: Unknown. No human milk data; it passes into rat milk. LactMed: as a large protein, milk levels are likely very low and poorly absorbed, but no data yet. US label: breastfeeding not recommended during treatment and for 3 months after the last dose.
What does Luspatercept interact with?
MediHelp does not list a checked interaction for Luspatercept yet. Always tell your pharmacist about every medicine you take.
Monographies complètes, posologies et vérificateur d'interactions dans l'application MediHelp
Ouvrez le référentiel complet, vérifiez les interactions entre plusieurs médicaments et utilisez les outils de posologie dans l'application MediHelp.
